Jeffrey Epstein reportedly planned to create a "genetically superior" human race using advanced genetic engineering and ...

The National Medical Commission (NMC) has released the official NEET UG 2026 syllabus, outlining the topics to be covered in ...

Vyriad announced $25M final tranche of its Series B to support the first-in-human testing of VV169, Vyriad’s in vivo CAR-T candidate.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

Discover why PayPal (PYPL) is a top 2026 stock pick with strong buybacks, new dividends, robust growth, and margin-expanding revenue streams. Click to read.

The post Gen Z does not exist: Why phony generational labels fail us appeared first on Salon.com.

Detailed price information for Sab Biotherapeutics Inc (SABS-Q) from The Globe and Mail including charting and trades.

Between 2025 and 2030, the DNA-Modified Plant Extracts Market is forecast to nearly double, climbing from USD 950.7 million ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the planned expansion of its state-of-the-art manufacturing facility in Norton, Massachusetts. The ...

Analyzing stochastic cell-to-cell variability can potentially reveal causal interactions in gene regulatory networks.

Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...